SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-23-269359
Filing Date
2023-11-02
Accepted
2023-11-02 16:05:36
Documents
16
Period of Report
2023-08-31
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d323300d8ka.htm   iXBRL 8-K/A 33724
2 EX-23.1 d323300dex231.htm EX-23.1 1896
3 EX-99.3 d323300dex993.htm EX-99.3 135080
4 EX-99.4 d323300dex994.htm EX-99.4 175899
5 EX-99.5 d323300dex995.htm EX-99.5 167998
  Complete submission text file 0001193125-23-269359.txt   718303

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mirm-20230831.xsd EX-101.SCH 2851
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20230831_lab.xml EX-101.LAB 19445
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20230831_pre.xml EX-101.PRE 12142
10 EXTRACTED XBRL INSTANCE DOCUMENT d323300d8ka_htm.xml XML 5189
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38981 | Film No.: 231372193
SIC: 2834 Pharmaceutical Preparations